DLDorothy Lombe

Dorothy Lombe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dorothy Lombe has a total of 182 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Editorial: Optimizing radiotherapy for cervical cancer efficacy toxicity and brachytherapy integration

    by Irina Vergalasova, Chunling Jiang, Tao Song, Dorothy Lombe

    In their piece, Mallum et al address resource limitation challenge by reducing the number of fractions required. 1 In the highly conformal era of volumetric arc therapy hypofractionation is a reasonable approach whilst acknowledging and respecting the radiobiological properties of tumor type and radiosensitivity. 2 A shortened course of radiotherapy in resource limited setting has important implications both for the institution and the patient. Many patients' undergoing treatment for cervical cancer are geographically displaced from their support systems. Acute toxicities typically emerge at approximately two weeks from commencement of treatment and peak in weeks for to six. A shortened treatment course may allow completion of therapy before the most severe toxicity phase, reducing both physical and socioeconomic burden. This represents a pragmatic form of optimization.Beyond fractionation, toxicity prediction and management were addressed by the submissions from Xue et al, Luo et al, Zhao et al and Fan et al. [3][4][5][6] These studies present evidence on integration of imaging and predictive modelling, which may help match patients with appropriate treatment regimen. Wu et al explored the use of a recombinant human endostatin to increase efficacy of treatment whilst maintain quality of life.. 7 Workflow innovation emerges as a critical determinant of treatment quality. MRI has been established as a gold standard for brachytherapy imaging. However, it will remain unreachable for most radiotherapy centers in Low-and Middle-Income Countries (LMICs) and in smaller regional centers in developed countries. Taking advantage of the improved image quality of cone beam CTs (CBCT) on modern radiotherapy machines the community may look in the direction of implementing the findings of Karius et al. 8 They introduced a cone beam-based approach to optimize needle placement and demonstrated measurable improvements in both geometric accuracy and dosimetry outcomes.Integration of artificial intelligence is now an expected part of practice to optimize resource utilization. The review from Shi et al provides an exquisite update on the position of AI integration in high dose rate brachytherapy for cervical cancer. 9 In close relation to big data is the ability to use modelling in development of diagnostic tools. 10,11 Lastly, Zhang and Alshdaifat interrogate tumor behavior, response and diagnostic modelling to guide treatment allocation. 12,13 We hope readers will find this collection provides meaningful insight and stimulates further progress in the optimization of cervical cancer radiotherapy.

  • Demographic and social determinants of human immunodeficiency virus status among women with cervical cancer in a low-resource setting

    by Ahmed O. Elmehrath, Bernadette Njala, Dyness Sakala, Graciela M. Nogueras-Gonzalez, Mark F. Munsell, Dorothy Chilambe Lombe, Swali Fundafunda, Mwando Chitula, Susan K. Peterson, Elizabeth Y. Chiao, et al.

  • Use of Interactive, Patient-Centric Mobile Health Technology in Sub-Saharan Africa: A Scoping Review

    by Kamaria L. Lee, Susan Citonje Msadabwe-Chikuni, Dorothy C. Lombe, Graciela M. Nogueras Gonzalez, Pavitra P. Krishnamani, Patrick P. Carriere, Austin Huang, Lango Sichizya, Elizabeth Yu Chiao, Kate J. Krause, et al.

    PURPOSE: Although significant differences in health care outcomes remain between low-middle–income countries and high-income countries, access to mobile devices is comparable. Interactive, patient-centric mobile health (mHealth) technology interventions may mitigate the increasing cancer burden in sub-Saharan Africa. However, these interventions' distribution, efficacy, and feasibility in the region are unknown. METHODS: We compiled literature on two-way, patient-centric mHealth technology in sub-Saharan Africa. We searched online databases for studies completed in sub-Saharan Africa with mHealth interventions (inception to July 23, 2024). Two authors independently completed title/abstract screening. Inclusion criteria were sub-Saharan African setting, age 13 years or older with any health condition, two-way mobile communication, and outcomes studies. Studies that passed title/abstract screening underwent full-text review by two independent authors. Discrepancies were resolved through consensus. Data extraction/review was completed using Covidence software and Microsoft Excel. RESULTS: We retrieved 1,380 unique citations. After screening/review, the final sample size was 37. Randomized controlled trials were most common (n = 20). A plurality took place in Kenya. HIV was the most common condition (n = 30). Interventions included messages about medication/appointment adherence and patient status. Most studies (32 of 37 [86%]) had at least one positive finding. Study characteristics varied widely for those with positive findings, but using various message frequencies, or peer navigators/social supporters increased success. All studies with no positive findings were randomized controlled trials; four of the five were on HIV. CONCLUSION: Most two-way, patient-centric mHealth interventions in sub-Saharan Africa have been successful by at least one measure. Interventions have primarily been for patients with HIV. No studies have focused on cancer. With the increasing cancer burden in sub-Saharan Africa, an understanding of mHealth in oncologic settings is greatly needed.


  • Open Access

    A multidisciplinary approach to strengthening patient navigation among gynaecologic malignancy patients at the Cancer Diseases Hospital in Zambia

    by Mupeta Songwe, Dorothy Lombe, Susan Msadabwe, Mukatimui Munalula, Paul Kamfwa, Swali Fundafunda, Emily Walubita, Samson Chisele, Victor Mudenda, Mulindi Mwanahamuntu, et al.

  • Open Access

    Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa

    by Dorothy Chilambe Lombe, Monde Mwamba, Musonda Simwinga, Virginia Bond, Andrew Sentoogo Ssemata, Richard Muhumuza, Janet Seeley, Kennedy Lishimpi, Victor Mapulanga, John Kachimba, et al.

    Objectives Locally led research on cancer is needed in sub-Saharan Africa to set feasible research priorities that inform national policy. The aim of this project was to develop a research agenda for national cancer control planning, using a nationally driven approach, focused on barriers to diagnosis and high-quality treatment for prostate cancer in Zambia. Methods and analysis This was a Delphi process. 29 stakeholders were scored barriers on feasibility, the proportion of patients affected, the impact on patient outcomes and if there was a potential to address health systems barriers meaningfully. There were three rounds (R) to the process: (R1 and R2) by electronic survey and (R3) in-person meeting. In R1 statements scoring above 15 from over 70% of participants were prioritised immediately for R3 discussion. Those scoring below 30% were dropped and those in between were re-surveyed in R2. Results 22 and 17 of the 29 stakeholders responded to R1 and R2. 14 stakeholders attended R3. National priority research areas for prostate cancer in Zambia were identified as prostate cancer awareness; building affordable high-quality diagnostic capacity; affordability of specialist cancer treatments; supporting better access to medicines; delivery and coordination of services across the pathway and staff training. Conclusion The suggested seven priority areas allow for the development of the prostate cancer control programme to be conducted in a holistic manner. The expectation is with this guidance international partners can contribute within the frameworks of the local agenda for sustainable development to be realised.


  • Open Access

    Challenges faced by women oncologists in Africa: a mixed methods study

    by Miriam Mutebi, Naa Adorkor Aryeetey, Haimanot Kasahun Alemu, Laura Carson, Zainab Mohamed, Zainab Doleeb, Nwamaka Lasebikan, Nazima Jaffer Dharsee, Susan Msadabwe, Doreen Ramogola-Masire, et al.

    Objective Recent studies have identified challenges facing women oncologists in Western contexts. However, similar studies in Africa have yet to be conducted. This study sought to determine the most common and substantial challenges faced by women oncologists in Africa and identify potential solutions. Methods and analysis A panel of 29 women oncologists from 20 African countries was recruited through professional and personal networks. A Delphi consensus process identified challenges faced by women oncologists in Africa, and potential solutions. Following this, focus group discussions were held to discuss the results. Descriptive statistics were used to identify the most common challenges indicated by participants and thematic analysis was conducted on focus group transcripts. Results African women oncologists experienced challenges at individual, interpersonal, institutional and societal levels. The top-ranked challenge identified in the Delphi study was ‘pressure to maintain a work–family balance and meet social obligations’. Some of the challenges identified were similar to those in studies on women oncologists outside of Africa while others were unique to this African demographic. Solutions to improve the experience of women oncologists were identified and discussed, including greater work flexibility and mentorship opportunities. Conclusion Women oncologists in Africa experience many of the challenges that have been previously identified by studies in other regions. These challenges and potential solutions exist at all levels of the social-ecological framework. Women oncologists must be empowered in number and leadership, and gender-sensitive curricula and competencies must be implemented. A systems-level dialogue could bring light to these challenges and foster tangible action and policy-level changes.


  • Open Access

    Moving forward through consensus: a national Delphi approach to determine the top research priorities in prostate cancer in Uganda

    by Andrew Sentoogo Ssemata, Richard Muhumuza, Janet Seeley, Dorothy Chilambe Lombe, Monde Mwamba, Susan Msadabwe, Amos Deogratius Mwaka, Ajay Aggarwal

    Objective To identify key areas for research in prostate cancer (PC) in the Ugandan context by establishing the major health system, socioeconomic and clinical barriers to seeking, reaching and receiving high-quality cancer care. Design Modified Delphi Technique. Setting Government and private-not-for-profit hospitals. Methods We applied a two-stage modified Delphi technique to identify the consensus view across cancer experts. In round 1, experts received a questionnaire containing 21 statements drawn from a systematic review identifying the reason for the delay in accessing cancer care. Each statement was scored out of 20. Statements scoring ≥15 from over 70% of participants were prioritised for inclusion while statements for which Results We found that the top six research priority areas arise from challenges including: (1) lack of diagnostic services—ultrasound, laboratory tests and biopsy facilities; (2) high costs of services, for example, surgery, radiotherapy, hormone therapy are unaffordable to most patients, (3) lack of essential medicines, (4) limited radiotherapy capacity, (5) lack of awareness of cancer as a disease and low recognition of symptoms, (6) low healthcare literacy. The lack of critical surgical supplies, high diagnostic and treatment costs were ranked highest in order of importance in round 1. Round 2 also revealed lack of diagnostic services, unavailability of critical medicines, lack of radiotherapy options, high costs of treatments and lack of critical surgical supplies as the top priorities. Conclusion These research priority areas ought to be addressed in future research to improve prompt PC diagnosis and care in Uganda. There is need to improve the supply of high-quality affordable anticancer medicines for PC patients so as to improve the survivorship from the cancer.


  • Open Access

    Moving forward through consensus: a national Delphi approach to determine the top research priorities in prostate cancer in Uganda

    by Andrew Sentoogo Ssemata, Richard Muhumuza, Janet Seeley, Dorothy Chilambe Lombe, Monde Mwamba, Susan Msadabwe, Amos Deogratius Mwaka, Ajay Aggarwal

    Objective To describe the health system, socioeconomic and clinical factors that influence access to and outcomes of care for prostate cancer (PC) in Uganda. Design Qualitative Delphi technique Setting Government and private-not-for-profit hospitals Methods We applied a two-stage modified Delphi technique to identify the consensus view across cancer experts. In the first round, experts received a questionnaire containing 22 statements drawn from a systematic review of the literature focusing on identifying the reason for the delay in accessing cancer care. Round 2 comprised 18 statements considered the greatest priority from round 1. Results We found that the top five research priority areas arise from challenges including: (i) lack of Diagnostic services - Ultrasound, laboratory tests, and biopsy facilities; (ii) High costs of services e.g., surgery, radiotherapy, hormone therapy are unaffordable to most patients, (iii) Lack of critical surgical supplies and essential/critical medicines, (iv) Lack of awareness of cancer as a disease and low recognition of symptoms, (v) Low Healthcare literacy. The lack of critical surgical supplies, high costs of diagnostic investigations and treatments were ranked highest in order of importance in round one. Round two of the survey also revealed lack of diagnostic services, unavailability of critical medicines, lack of radiotherapy options, high costs of treatments and lack of critical surgical supplies as the top priorities. Conclusion These research priority areas ought to be addressed in future research to improve prompt prostate cancer diagnosis and care in Uganda. There is need to improve the supply of high-quality affordable anticancer medicines provided timely to prostate cancer patients so as to improve the survivorship from the cancer. Strengths and limitations of this study This is a novel Delphi study exploring research priorities for prostate cancer research in Uganda from various stakeholders in cancer care. The study was informed by a recent systematic review which provided insight into the statements explored in the Delphi technique. Participants were recruited from various clinical, government aided and private settings and geographical locations giving representativeness of the participants. A limitation to this study was the low response rates in round 1 and round 2 as most stakeholders were not familiar with the Delphi technique, or how it works.

  • Open Access

    Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review

    by Dorothy Chilambe Lombe, Monde Mwamba, Susan Msadabwe, Virginia Bond, Musonda Simwinga, Andrew Sentoogo Ssemata, Richard Muhumuza, Janet Seeley, Amos Deogratius Mwaka, Ajay Aggarwal

    Objectives Late presentation and delays in diagnosis and treatment consistently translate into poor outcomes in sub-Saharan Africa (SSA). The aim of this study was to collate and appraise the factors influencing diagnostic and treatment delays of adult solid tumours in SSA. Design Systematic review with assessment of bias using Risk of Bias in Non-randomised Studies of Exposures (ROBINS-E) tool. Data sources PubMed and Embase, for publications from January 1995 to March 2021. Eligibility criteria Inclusion criteria: quantitative or mixed-method research, publications in English, on solid cancers in SSA countries. Exclusion criteria: paediatric populations, haematologic malignancies, and assessments of public perceptions and awareness of cancer (since the focus was on patients with a cancer diagnosis and treatment pathways). Data extraction and synthesis Two reviewers extracted and validated the studies. Data included year of publication; country; demographic characteristics; country-level setting; disease subsite; study design; type of delay, reasons for delay and primary outcomes. Results 57 out of 193 full-text reviews were included. 40% were from Nigeria or Ethiopia. 70% focused on breast or cervical cancer. 43 studies had a high risk of bias at preliminary stages of quality assessment. 14 studies met the criteria for full assessment and all totaled to either high or very high risk of bias across seven domains. Reasons for delays included high costs of diagnostic and treatment services; lack of coordination between primary, secondary and tertiary healthcare sectors; inadequate staffing; and continued reliance on traditional healers and complimentary medicines. Conclusions Robust research to inform policy on the barriers to quality cancer care in SSA is absent. The focus of most research is on breast and cervical cancers. Research outputs are from few countries. It is imperative that we investigate the complex interaction of these factors to build resilient and effective cancer control programmes.


  • Open Access

    Secondary Prevention of Cervical Cancer: ASCO Resource–Stratified Guideline Update

    by Surendra S. Shastri, Sarah Temin, Maribel Almonte, Partha Basu, Nicole G. Campos, Patty E. Gravitt, Vandana Gupta, Dorothy C. Lombe, Rául Murillo, Carolyn Nakisige, et al.

    PURPOSE: To update resource-stratified, evidence-based recommendations on secondary prevention of cervical cancer globally. METHODS: American Society of Clinical Oncology convened a multidisciplinary, multinational Expert Panel to produce recommendations reflecting four resource-tiered settings. A review of existing guidelines, formal consensus-based process, and modified ADAPTE process to adapt existing guidelines was conducted. Other experts participated in formal consensus. RESULTS: This guideline update reflects changes in evidence since the previous update. Five existing guidelines were identified and reviewed, and adapted recommendations form the evidence base. Cost-effectiveness analyses provided indirect evidence to inform consensus, which resulted in ≥ 75% agreement. RECOMMENDATIONS: Human papillomavirus (HPV) DNA testing is recommended in all resource settings; visual inspection with acetic acid may be used in basic settings. Recommended age ranges and frequencies vary by the following setting: maximal: age 25-65 years, every 5 years; enhanced: age 30-65 years, if two consecutive negative tests at 5-year intervals, then every 10 years; limited: age 30-49 years, every 10 years; basic: age 30-49 years, one to three times per lifetime. For basic settings, visual assessment is used to determine treatment eligibility; in other settings, genotyping with cytology or cytology alone is used to determine treatment. For basic settings, treatment is recommended if abnormal triage results are obtained; in other settings, abnormal triage results followed by colposcopy is recommended. For basic settings, treatment options are thermal ablation or loop electrosurgical excision procedure; for other settings, loop electrosurgical excision procedure or ablation is recommended; with a 12-month follow-up in all settings. Women who are HIV-positive should be screened with HPV testing after diagnosis, twice as many times per lifetime as the general population. Screening is recommended at 6 weeks postpartum in basic settings; in other settings, screening is recommended at 6 months. In basic settings without mass screening, infrastructure for HPV testing, diagnosis, and treatment should be developed. Additional information is available at www.asco.org/resource-stratified-guidelines .